Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 114, Issue 1, 2004, Pages 137-143

  Schuller, Erika ^a   Oppel, Tilmann ^a   Bornhövd, Elke ^a   Wetzel, Stefanie ^a   Wollenberg, Andreas ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

7 Amino actinomycin D; 7AAD; AD; Atopic dermatitis; atopic eczema; Epidermal dendritic cells; flow cytometry; Forward light scatter; FSC; IDEC; Inflammatory dendritic epidermal cell; Langerhans cell; LC; MFI; steroid ointment; topical immunomodulators

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DNA NUCLEOTIDYLEXOTRANSFERASE; HYDROCORTISONE BUTYRATE; LIPOCORTIN 5; STEROID; TACROLIMUS;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; ATOPIC DERMATITIS; CELL COUNT; CELL ISOLATION; CELL SUSPENSION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; DRUG MECHANISM; EPIDERMIS CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; INFLAMMATORY CELL; LANGERHANS CELL; MOLECULE; MONOCYTE; NICK END LABELING; OINTMENT; PRIORITY JOURNAL; STANDARDIZATION;

ADMINISTRATION, TOPICAL; APOPTOSIS; CELL CULTURE TECHNIQUES; DENDRITIC CELLS; DERMATITIS, ATOPIC; EPIDERMIS; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IN SITU NICK-END LABELING; LANGERHANS CELLS; OINTMENTS; TACROLIMUS;

EID: 3442880124     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.03.021     Document Type: Article

References (23)

1. Wollenberg A., Bieber T. Atopic dermatitis: from the genes to skin lesions. Allergy. 55:2000;205-213
2. Leung D.Y., Bieber T. Atopic dermatitis. Lancet. 361:2003;151-160
3. Bornhövd E., Burgdorf W.H.C., Wollenberg A. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases. J Am Acad Dermatol. 45:2001;736-743
4. Wollenberg A., Kraft S., Hanau D., Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol. 106:1996;446-453
5. Wollenberg A., Sharma S., von Bubnoff D., Geiger E., Haberstok J., Bieber T. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J Allergy Clin Immunol. 107:2001;519-525
6. Hashimoto Y., Matsuoka N., Kawakami A., Tsuboi M., Nakashima T., Eguchi K., et al. Novel immunosuppressive effect of FK506 by augmentation of T cell apoptosis. Clin Exp Immunol. 125:2001;19-24
7. Kochi S., Takanaga H., Matsuo H., Ohtani H., Naito M., Tsuruo T., et al. Induction of apoptosis in mouse brain capillary endothelial cells by cyclosporin A and tacrolimus. Life Sci. 66:2000;2255-2260
8. Wollenberg A. Isolation and enrichment of human epidermal Langerhans cells. Cochet O., Teillaud J., Sautes C. Immunological techniques made easy. 1998;20-22 Wiley, Chichester
9. Kraft S., Novak N., Katoh N., Bieber T., Rupec R.A. Aggregation of the high-affinity IgE receptor Fc(epsilon)RI on human monocytes and dendritic cells induces NF-kappaB activation. J Invest Dermatol. 118:2002;830-837
10. Wollenberg A., Wen S., Bieber T. Phenotyping of epidermal dendritic cells - clinical applications of a flow cytometric micromethod. Cytometry. 37:1999;147-155
11. Reitamo S., Rustin M., Ruzicka T., Cambazard F., Kalimo K., Friedmann P.S., et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol. 109:2002;547-555
12. Freeman J., Cardoso A.A., Boussiotis V.A., Anumanthan A., Groves R.W., Kupper T.S., et al. The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptor. J Immunol. 161:1998;2708-2715
13. Panhans-Groß A., Novak N., Kraft S., Bieber T. Human epidermal Langerhans cells are targets for the immunosuppressive macrolide tacrolimus (FK506). J Allergy Clin Immunol. 107:2001;345-352
14. Wollenberg A., Wen S., Bieber T. Langerhans cell phenotyping: a new tool for differential diagnosis of inflammatory skin diseases. Lancet. 346:1995;1626-1627
15. Brokaw J.J., White G.W., Baluk P., Anderson G.P., Umemoto E.Y., McDonald D.M. Glucocorticoid-induced apoptosis of dendritic cells in the rat tracheal mucosa. Am J Respir Cell Mol Biol. 19:1998;598-605
16. Kim K.D., Choe Y.K., Choe I.S., Lim J.S. Inhibition of glucocorticoid-mediated, caspase-independent dendritic cell death by CD40 activation. J Leukoc Biol. 69:2001;426-434
17. Yardin C., Terro F., Lesort M., Esclaire F., Hugon J. FK506 antagonizes apoptosis and c-jun protein expression in neuronal cultures. Neuroreport. 9:1998;2077-2080
18. Kalthoff F.S., Chung J., Musser P., Stütz A. Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corticosteroids. Clin Exp Immunol. 133:2003;350-359
19. Meingassner J.G., Kowalsky E., Schwendinger H., Elbe-Burger A., Stütz A. Pimecrolimus does not affect Langerhans cells in murine epidermis. Br J Dermatol. 149:2003;853-857
20. Szabo G., Gavala C., Mandrekar P. Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells. J Investig Med. 49:2001;442-449
21. Salgado C.G., Nakamura K., Sugaya M., Tada Y., Asahina A., Fukuda S., et al. Differential effects of cytokines and immunosuppressive drugs on CD40, B7-1, and B7-2 expression on purified epidermal Langerhans cells1. J Invest Dermatol. 113:1999;1021-1027
22. Bellinghausen I., Brand U., Steinbrink K., Enk A.H., Knop J., Saloga J. Inhibition of human allergic T-cell responses by IL-10-treated dendritic cells: differences from hydrocortisone-treated dendritic cells. J Allergy Clin Immunol. 108:2001;242-249
23. Schuller E., Teichmann B., Haberstok J., Moderer M., Bieber T., Wollenberg A. In situ-expression of the costimulatory molecules CD80 and CD86 on Langerhans cells and inflammatory dendritic epidermal cells (IDEC) in atopic dermatitis. Arch Dermatol Res. 293:2001;448-454